Disease Info Card

Lymphatic Diseases

Information about Lymphatic Diseases: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Lymphatic Diseases

Most recent studies have shown that Lymphatic Diseases shares some biological mechanisms with acquired-immunodeficiency-syndrome, carcinoma, dermatologic-disorders, granuloma, histiocytosis, histiocytosis-langerhans-cell, hodgkin-disease, hyperplasia, leukemia, lung-diseases, lymphatic-metastasis, lymphoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, mucocutaneous-lymph-node-syndrome, neoplasm-metastasis, neoplasms, reticulosis-nos, sarcoidosis, skin-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Lymphatic Diseases, and have been seen in publications frequently: Angiogenesis, Cell Activation, Cell Death, Cell Differentiation, Cell Proliferation, Coagulation, Excretion, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Lymph Circulation, Lymphangiogenesis, Lymphocyte Proliferation, Pathogenesis, Phagocytosis, Regeneration, Secretion, T Cell Activation, Transport

Quite a number of genes have been found to play important roles in Lymphatic Diseases, such as CAT, CD4, CD8A, CRAT, CRP, CTLA4, FAS, GLYAT, HLA-DQA1, IL2, IL6, KRT20, LYZ, MS4A1, NOD2, PTPRC, TNF, TNFRSF8. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.